BQU57 (S7607): Selective Kinase Inhibitor Overview

BQU57 is a selective small-molecule kinase inhibitor (Selleck catalog number S7607) available from Aladdin Scientific (SKU B413791) for use in oncology and cell-signaling research.

Selleck Catalog Number

S7607

Aladdin SKU

B413791

Compound Class

Small-molecule kinase inhibitor

Primary Research Application

Oncology and cell-signaling studies

Format

Research-grade reagent (solid or solution; confirm with CoA)

What Is BQU57?

BQU57 is a small-molecule inhibitor cataloged by Selleck Chemicals under the identifier S7607 and supplied by Aladdin Scientific under SKU B413791. Small-molecule kinase inhibitors such as BQU57 are widely employed in preclinical research to dissect intracellular signaling pathways, validate drug targets, and evaluate the therapeutic potential of kinase inhibition in disease models. BQU57 belongs to a class of compounds designed to competitively or allosterically block kinase activity, thereby modulating downstream signaling cascades relevant to cell proliferation, survival, and apoptosis.

Note: Detailed mechanistic data (target identity, IC₅₀ values, selectivity panel) should be confirmed against the supplier's current technical datasheet and peer-reviewed literature prior to experimental use.

Research Applications

BQU57 is intended for in vitro and in vivo preclinical research applications. Typical uses for selective kinase inhibitors of this class include:

• Target validation: Confirming the biological role of the inhibited kinase by phenotypic rescue or epistasis experiments.
• Pathway analysis: Mapping upstream and downstream effectors of the relevant signaling axis using western blotting, phosphoproteomics, or reporter assays.
• Cell viability and apoptosis assays: Determining the antiproliferative or pro-apoptotic effects of kinase blockade in cancer cell lines.
• Combination studies: Assessing synergy or antagonism when BQU57 is paired with chemotherapeutic agents or other targeted inhibitors.

Researchers should consult the primary literature and the supplier datasheet to confirm validated assay conditions, including cell line suitability, concentration ranges, and treatment durations.

Preparation and Handling

Proper preparation and storage of small-molecule inhibitors are critical for reproducible results. The following general guidelines apply to research-grade compounds such as BQU57; always cross-reference the product Certificate of Analysis (CoA) for lot-specific instructions:

• Solubility: Many kinase inhibitors are soluble in dimethyl sulfoxide (DMSO). Prepare a concentrated stock solution (e.g., 10–50 mM) in DMSO and aliquot to avoid repeated freeze–thaw cycles. Confirm solubility data on the current CoA.
• Storage: Store as indicated on the product label, typically at −20 °C or −80 °C under desiccating conditions, protected from light.
• Working solutions: Dilute the DMSO stock into aqueous cell culture medium immediately before use. Keep the final DMSO concentration ≤0.1% (v/v) to minimise solvent cytotoxicity; always include a vehicle control.
• Stability: Reconstituted solutions should be used promptly or stored per CoA guidance. Do not use product beyond the stated expiry date.

Safety and Regulatory Considerations

BQU57 is supplied for research use only (RUO) and is not approved for human or veterinary therapeutic use. Researchers must observe standard laboratory safety practices:

• Consult the Safety Data Sheet (SDS) before handling. Treat all novel small molecules as potentially hazardous.
• Use appropriate personal protective equipment (PPE): lab coat, nitrile gloves, and eye protection.
• Handle DMSO stock solutions in a well-ventilated area or fume hood, as DMSO can enhance dermal absorption of co-dissolved compounds.
• Dispose of chemical waste in accordance with institutional and local regulations.

For SDS requests, CoA downloads, or compliance documentation, contact Aladdin Scientific customer service or visit the product page for SKU B413791.

Frequently asked questions

What is the Selleck catalog number for BQU57?

BQU57 is listed under Selleck catalog number S7607. At Aladdin Scientific it is available under SKU B413791.

In what solvent should BQU57 be dissolved?

Small-molecule kinase inhibitors of this class are commonly dissolved in DMSO to prepare a concentrated stock solution. Always verify the recommended solvent and confirmed solubility on the product's Certificate of Analysis before use.

Is BQU57 suitable for in vivo studies?

BQU57 is a research-grade reagent that may be used in preclinical in vivo studies, subject to appropriate formulation and institutional ethics approval. Researchers should consult the primary literature and datasheet for validated in vivo formulation protocols, dosing, and pharmacokinetic data.

How should BQU57 be stored to maintain stability?

Generally, research-grade small molecules should be stored at −20 °C or −80 °C in a desiccated, light-protected environment. Aliquot stock solutions to avoid repeated freeze–thaw cycles. Refer to the lot-specific CoA for precise storage conditions and shelf life.

Can BQU57 be used in combination with other inhibitors?

Combination studies are a common application for selective kinase inhibitors. However, synergy, additivity, or antagonism must be empirically determined for each specific combination and cell model. Consult published combination-index analyses and establish appropriate controls, including individual drug and vehicle controls.

References

1. Selleck Chemicals. BQU57 (S7607) product datasheet. Selleck Chemicals LLC.
2. Aladdin Scientific. BQU57 (B413791) product page. Aladdin Scientific.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.